Search

Your search keyword '"Arver, B."' showing total 208 results

Search Constraints

Start Over You searched for: Author "Arver, B." Remove constraint Author: "Arver, B."
208 results on '"Arver, B."'

Search Results

1. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

4. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

5. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

6. Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort Consortium

7. Alcohol consumption, cigarette smoking, and risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Results from the BRCA1 and BRCA2 cohort consortium.

8. Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness.

9. Erratum: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: An international prospective cohort of BRCA1 and BRCA2 mutation carriers (Breast Cancer Res (2020) 22 (8) DOI: 10.1186/s13058-020-1247-4).

10. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: An international prospective cohort of BRCA1 and BRCA2 mutation carriers.

11. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers (vol 22, 8, 2020)

12. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

13. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

14. Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort Consortium

16. The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations

18. The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations

19. Individuals with &ITFANCM&IT biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility

21. The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations

22. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

23. Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers

26. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

27. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

28. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

29. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

30. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

31. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

32. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

33. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

34. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

35. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

36. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

37. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

38. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

39. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

40. DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

41. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers.

42. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

43. Identification of six new susceptibility loci for invasive epithelial ovarian cancer

44. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

47. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

48. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers

49. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

50. Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers

Catalog

Books, media, physical & digital resources